Platelet microparticle levels: a biomarker of thromboangiitis obliterans (Buerger's disease) exacerbation.

Journal of cellular and molecular medicine ·Vol. 14 ·No. 1-2 ·2010-01-00 ·Pages 449-51

Darnige L, Helley D, Fischer AM, Emmerich J, Smadja DM, Fiessinger JN

Abstract

暂无摘要

MeSH Terms

Adult Aged Biomarkers/metabolism Blood Platelets/cytology,metabolism,pathology Cell-Derived Microparticles/metabolism Female Humans Male Middle Aged Prospective Studies Smoking/adverse effects Thromboangiitis Obliterans/blood,pathology Tobacco

Chemicals

Biomarkers

Authors & Affiliations

6 authors, click to expand affiliations / ORCID

Darnige L

Helley D

Fischer A M

Emmerich J

Smadja D M

Fiessinger J N

References (18)

18 references, click to expand

A point scoring system for the clinical diagnosis of Buerger's disease.
Eur J Vasc Endovasc Surg. 1996 Apr;11(3):335-9 PMID: 8601245
Platelet-derived microparticles in patients with arteriosclerosis obliterans: enhancement of high shear-induced microparticle generation by cytokines.
Thromb Res. 2000 May 15;98(4):257-68 PMID: 10822072
Transcellular activation of platelets and endothelial cells by bioactive lipids in platelet microparticles.
J Clin Invest. 1997 May 1;99(9):2118-27 PMID: 9151784
Thromboangiitis obliterans (Buerger's disease).
N Engl J Med. 2000 Sep 21;343(12):864-9 PMID: 10995867
Standardization of platelet-derived microparticle counting using calibrated beads and a Cytomics FC500 routine flow cytometer: a first step towards multicenter studies?
J Thromb Haemost. 2009 Jan;7(1):190-7 PMID: 18983485
Circulating microparticles: a marker of procoagulant state in normal pregnancy and pregnancy complicated by preeclampsia or intrauterine growth restriction.
Thromb Haemost. 2003 Mar;89(3):486-92 PMID: 12624632
Procoagulant microparticles: disrupting the vascular homeostasis equation?
Arterioscler Thromb Vasc Biol. 2006 Dec;26(12):2594-604 PMID: 16990554
Microparticles in cardiovascular diseases.
Cardiovasc Res. 2003 Aug 1;59(2):277-87 PMID: 12909311
Platelet microparticles and soluble P selectin in peripheral artery disease: relationship to extent of disease and platelet activation markers.
Ann Med. 2005;37(1):61-6 PMID: 15902848
Cellular sensitivity to collagen in thromboangiitis obliterans.
N Engl J Med. 1983 May 12;308(19):1113-6 PMID: 6835334
Circulating microparticles: pathophysiology and clinical implications.
Blood Rev. 2007 May;21(3):157-71 PMID: 17118501
Platelet aggregation induced by ADP or epinephrine is enhanced in habitual smokers.
Thromb Res. 2000 Mar 1;97(5):287-95 PMID: 10709904
Platelet microparticles: a potential predictive factor of survival in hormone-refractory prostate cancer patients treated with docetaxel-based chemotherapy.
Eur Urol. 2009 Sep;56(3):479-84 PMID: 18585841
Circulating endothelial cells, microparticles and progenitors: key players towards the definition of vascular competence.
J Cell Mol Med. 2009 Mar;13(3):454-71 PMID: 19379144
Microparticles in vascular diseases.
Thromb Res. 2008;122 Suppl 1:S55-9 PMID: 18691501
Quantitative determination of circulating platelet microparticles by flow cytometry.
Int J Cardiol. 1994 Dec;47(1 Suppl):S13-19 PMID: 7737747
Trial of iloprost versus aspirin treatment for critical limb ischaemia of thromboangiitis obliterans. The TAO Study.
Lancet. 1990 Mar 10;335(8689):555-7 PMID: 1689791
Antiphospholipid antibodies in thromboangiitis obliterans.
Vasc Med. 2002;7(4):259-64 PMID: 12710840

Article Info

Journal

Journal of cellular and molecular medicine

Abbr.

J Cell Mol Med

ISSN

1582-4934

DOI

10.1111/j.1582-4934.2009.00928.x

Published

2010-01-00

Epub

2009-00-10

Pages

449-51

Language

English

Region

England

NLM ID

101083777

PMCID

PMC3837587

Subset

External Links

PubMed source DOI: 10.1111/j.1582-4934.2009.00928.x PMC Full Text View journal details

Analysis Services

Platelet microparticle levels: a biomarker of thromboangiitis obliterans (Buerger's disease) exacerbation.

Contact

WeChat Official Account